These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630 [TBL] [Abstract][Full Text] [Related]
5. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease. Isaacsohn JL; Davidson MH; Hunninghake D; Singer R; McLain R; Black DM Am J Cardiol; 2000 Jul; 86(2):250-2. PubMed ID: 10913499 [No Abstract] [Full Text] [Related]
6. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study]. März W MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971 [TBL] [Abstract][Full Text] [Related]
7. Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with Atorvastatin Versus Revascularization Treatments (AVERT). McCormick LS; Black DM; Waters D; Brown WV; Pitt B Am J Cardiol; 1997 Nov; 80(9):1130-3. PubMed ID: 9359537 [TBL] [Abstract][Full Text] [Related]
8. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Ghali JK Am J Cardiol; 1998 Sep; 82(5):703. PubMed ID: 9732912 [No Abstract] [Full Text] [Related]
9. Atorvastatin versus simvastatin. Calder RA Am J Cardiol; 1997 Dec; 80(12):1646. PubMed ID: 9416964 [No Abstract] [Full Text] [Related]
10. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease. Clearfield M Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005 [No Abstract] [Full Text] [Related]
11. Antioxidant therapy for coronary artery disease: don't paint the walls without treating the termites! Ewy GA Arch Intern Med; 1999 Jun; 159(12):1279-80. PubMed ID: 10386503 [No Abstract] [Full Text] [Related]
12. ["Treating to New Targets": plea for a LDL cholesterol target of or below 75 mg/dl in any patient with coronary heart disease]. Scheen AJ Rev Med Liege; 2005 Apr; 60(4):264-7. PubMed ID: 15943105 [TBL] [Abstract][Full Text] [Related]
13. [Disturbances in cholesterol metabolism]. Marschall HU Dtsch Med Wochenschr; 2001 Jan; 126(3):63-4. PubMed ID: 11205483 [No Abstract] [Full Text] [Related]
14. [Clinical study of the month. REVERAL and PROVE-IT: confirmation of the concept " the lower, the better" for cholesterol therapy in patients with coronary heart disease]. Scheen AJ; Kulbertus H Rev Med Liege; 2004 Mar; 59(3):167-73. PubMed ID: 15139406 [TBL] [Abstract][Full Text] [Related]
15. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)]. März W MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673 [No Abstract] [Full Text] [Related]
16. Percutaneous coronary intervention versus medical therapy for coronary heart disease. Maron DJ Curr Atheroscler Rep; 2000 Jul; 2(4):290-6. PubMed ID: 11122756 [TBL] [Abstract][Full Text] [Related]
17. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering]. Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699 [No Abstract] [Full Text] [Related]
18. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073 [TBL] [Abstract][Full Text] [Related]